clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
NHS BRCA Testing for Those with Jewish Ancestry Huge Success
News & Features
Wearable Devices Can Predict Inflammatory Bowel Disease Flare-Ups
News & Features
Xenon Gas Inhalation Shows Promise for Alzheimer’s Disease
News & Features
Researchers Identify Immune Cells That Worsen Severe Asthma
News & Features
Breast Cancer Drug Shows Promise in Treating Blood Cancers
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Podcasts
Learning Labs
Inside Precision Medicine Live
Inside Precision Medicine
Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies
Caribou Biosciences
News & Features
Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies
July 26, 2021
0
News & Features
CRISPR Therapeutics Company Caribou Biosciences Plans $100M IPO
July 6, 2021
0
News & Features
3rd European CRISPR Patent Granted to U. of California, Charpentier, U. of Vienna
April 5, 2019
0
Related Content
NHS BRCA Testing for Those with Jewish Ancestry Huge Success
Boston-Based MedTherapy Announces New Tools for CAR-T Manufacturing
Tongue Cancer Organoids Reveal Key Pathways for Overcoming Drug Resistance
Mayo Clinic, Ambry Genetics Functionally Map 99% of all BRCA2 Hotspot SNVs
Inside Precision Medicine
![CRISPR Therapeutics and Massachusetts General Hospital Cancer Center said they will use CRISPR/Cas9 gene editing to develop novel T cell therapies for blood and solid tumors. [Source: Feng Zhang and Steve Dixo]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1218.jpeg "Caribou Biosciences’ IPO Hauls in $304M to Fund Development of Gene-Edited Cell Therapies")
